These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Neurourol Urodyn; 2012 Mar; 31(3):300-8. PubMed ID: 22275187 [Abstract] [Full Text] [Related]
43. Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries. Kozłowska H, Schlicker E, Kozłowski M, Siedlecka U, Laudański J, Malinowska B. J Cardiovasc Pharmacol; 2005 Jul; 46(1):76-82. PubMed ID: 15965358 [Abstract] [Full Text] [Related]
44. β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions? Igawa Y, Aizawa N, Michel MC. Br J Pharmacol; 2019 Jul; 176(14):2525-2538. PubMed ID: 30868554 [Abstract] [Full Text] [Related]
46. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637 [Abstract] [Full Text] [Related]
47. Selective β₃-adrenoceptor agonists for the treatment of overactive bladder. Andersson KE, Martin N, Nitti V. J Urol; 2013 Oct; 190(4):1173-80. PubMed ID: 23458471 [Abstract] [Full Text] [Related]
48. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. Hicks A, McCafferty GP, Riedel E, Aiyar N, Pullen M, Evans C, Luce TD, Coatney RW, Rivera GC, Westfall TD, Hieble JP. J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794 [Abstract] [Full Text] [Related]
50. Inhibition of cholinergic neurotransmission by β3-adrenoceptors depends on adenosine release and A1-receptor activation in human and rat urinary bladders. Silva I, Costa AF, Moreira S, Ferreirinha F, Magalhães-Cardoso MT, Calejo I, Silva-Ramos M, Correia-de-Sá P. Am J Physiol Renal Physiol; 2017 Aug 01; 313(2):F388-F403. PubMed ID: 28446460 [Abstract] [Full Text] [Related]
51. β3-adrenoceptor agonists inhibit carbachol-evoked Ca2+ oscillations in murine detrusor myocytes. Griffin CS, Bradley E, Hollywood MA, McHale NG, Thornbury KD, Sergeant GP. BJU Int; 2018 Jun 01; 121(6):959-970. PubMed ID: 29211339 [Abstract] [Full Text] [Related]
52. Fenoterol functionally activates the β₃-adrenoceptor in human urinary bladder, comparison with rat and mouse: implications for drug discovery. Palea S, Rekik M, Rouget C, Camparo P, Botto H, Rischmann P, Lluel P, Westfall TD. Eur J Pharmacol; 2012 Sep 05; 690(1-3):202-6. PubMed ID: 22760074 [Abstract] [Full Text] [Related]
57. Prophylactic role of oral L-arginine on histological and contractile changes in a rat chronic bladder injury model. Ozgür A, Onol FF, Ercan F, Tarcan T. Urol Int; 2008 Sep 05; 81(3):347-52. PubMed ID: 18931556 [Abstract] [Full Text] [Related]
58. TRK-380, a novel selective human β3-adrenoceptor agonist, ameliorates formalin-induced pollakiuria in rats and carbachol-induced bladder contraction in dogs. Kanie S, Otsuka A, Yoshikawa S, Kobayashi R, Itaba S, Yokokawa H, Tajima Y, Ozono S, Hayashi R, Mochizuki H. Urology; 2013 Oct 05; 82(4):975.e7-975.e12. PubMed ID: 24075004 [Abstract] [Full Text] [Related]